These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 34465825

  • 1. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
    Kim H, Jung G, Kim JH, Byun SS, Hong SK.
    Sci Rep; 2021 Aug 31; 11(1):17447. PubMed ID: 34465825
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3 + 4.
    Kim H, Kim JK, Hong SK, Jeong CW, Ku JH, Kwak C.
    World J Urol; 2021 Jun 31; 39(6):1825-1830. PubMed ID: 32869150
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological factors associated with pathological upgrading from biopsy to prostatectomy in patients with ISUP grade group ≤2 prostate cancer.
    Li X, Wang ZX, Zhu YP, Wang J, Yin YS, Zeng XY.
    Asian J Androl; 2022 Jun 31; 24(5):487-493. PubMed ID: 35170453
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.
    Helpap B, Ringli D, Tonhauser J, Poser I, Breul J, Gevensleben H, Seifert HH.
    Pathol Oncol Res; 2016 Apr 31; 22(2):349-56. PubMed ID: 26563277
    [Abstract] [Full Text] [Related]

  • 7. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer.
    Guazzoni G, Lazzeri M, Nava L, Lughezzani G, Larcher A, Scattoni V, Gadda GM, Bini V, Cestari A, Buffi NM, Freschi M, Rigatti P, Montorsi F.
    Eur Urol; 2012 Mar 31; 61(3):455-66. PubMed ID: 22078333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis.
    Kesch C, Pantea V, Soeterik T, Marquis A, la Bombarda G, Morlacco A, Barletta F, Radtke JP, Darr C, Preisser F, Zattoni F, Marra G, van den Bergh RCN, Hadaschik B, Gandaglia G, EAU-YAU Prostate Cancer Working Party.
    World J Urol; 2023 Feb 31; 41(2):427-434. PubMed ID: 36534151
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
    Zhai L, Fan Y, Sun S, Wang H, Meng Y, Hu S, Wang X, Yu W, Jin J.
    Scand J Urol; 2018 Feb 31; 52(5-6):333-339. PubMed ID: 30895901
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL.
    Ferro M, Crocetto F, La Civita E, Fiorenza M, Jannuzzi G, Carbone G, Sirica R, Sicignano E, Pagano G, Imbimbo C, Terracciano D.
    Prostate; 2024 Sep 31; 84(12):1157-1164. PubMed ID: 38798011
    [Abstract] [Full Text] [Related]

  • 15. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA, Schieda N, Keefe DT, Breau RH, Morash C, Hogan K, Belanger EC, Mai KT, Robertson SJ.
    Virchows Arch; 2016 Sep 31; 469(3):313-9. PubMed ID: 27394432
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MRI-based PI-RADS score predicts ISUP upgrading and adverse pathology at radical prostatectomy in men with biopsy ISUP 1 prostate cancer.
    Dekalo S, Mazliah O, Barkai E, Bar-Yosef Y, Herzberg H, Bashi T, Fahoum I, Barnes S, Sofer M, Yossepowitch O, Keren-Paz G, Mano R.
    Can J Urol; 2024 Aug 31; 31(4):11955-11962. PubMed ID: 39217520
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsy.
    De Luca S, Fiori C, Bollito E, Garrou D, Aimar R, Cattaneo G, De Cillis S, Manfredi M, Tota D, Federica M, Passera R, Porpiglia F.
    Minerva Urol Nefrol; 2020 Jun 31; 72(3):360-368. PubMed ID: 31619029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.